Patents by Inventor Lily Wang

Lily Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma
    Publication number: 20080300286
    Abstract: The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims.
    Type: Application
    Filed: March 2, 2005
    Publication date: December 4, 2008
    Inventors: Song Li, Xinbo Zhou, Lili Wang, Cheng Xu, Chengrnai Ruan, Cuifang Lin, Junhai Xiao, Zhibing Zhen, Hongying Liu, Yunde Xie, Zhong Wu, Hao Cui
  • Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulator
    Patent number: 7304057
    Abstract: This invention relates to substituted 6-membered N-Herterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof, wherein R1, R2, X, Y, and Z are as defined in the description; their preparation methods, compositions comprising the same, and their use as inhibitors of FK560 binding proteases activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injuries or other related diseases
    Type: Grant
    Filed: December 5, 2002
    Date of Patent: December 4, 2007
    Assignee: Institute of Pharmacology and Toxicology Accademy of Military Medical Sciences P.L.A. China
    Inventors: Song Li, Aihua Nie, Beifen Shen, Lili Wang, Wuhong Pei, Junhai Xiao, Songcheng Yang, Liuhong Yun, Hongying Liu, Cuiling Shu, Hongxia Wang, Zihe Rao
  • Substitued A-Piperazingly Phenylpropionic Acid Derivatives As Hppar Alpha And/Or Hppar Gamma Agonists
    Publication number: 20070259883
    Abstract: The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims.
    Type: Application
    Filed: February 2, 2005
    Publication date: November 8, 2007
    Applicant: BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Song Li, Xinbo Zhou, Lili Wang, Cheng Xu, Chengmai Ruan, Cuifang Lin, Junhai Xiao, Zhibing Zheng, Hongying Liu, Yunde Xie, Wu Zhong, Hao Cui
  • Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases
    Patent number: 7262183
    Abstract: This invention relates to substituted 5-membered N-Herterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof, wherein R1, R2, R3, R4, V, W, X, Y, and Z are as defined in the description; their preparation methods, compositions comprising the same, and their use as inhibitors of FK560 binding proteases (FKBPs) activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injuries or other related diseases.
    Type: Grant
    Filed: December 5, 2002
    Date of Patent: August 28, 2007
    Assignees: Instititute of Pharmacology and Toxicology, Academy of Military Medical Sciences P.L.A.
    Inventors: Song Li, Liqin Zhao, Lili Wang, Beifen Shen, Liuhong Yun
  • Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases
    Publication number: 20050171166
    Abstract: This invention relates to substituted 5-membered N-Herterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof, wherein R1, R2, R3, R4, V, W, X, Y, and Z are as defined in the description; their preparation methods, compositions comprising the same, and their use as inhibitors of FK560 binding proteases (FKBPs) activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injuries or other related diseases.
    Type: Application
    Filed: December 5, 2002
    Publication date: August 4, 2005
    Inventors: Song Li, Liqin Zhao, Lili Wang, Beifen Shen, Liuhong Yun
  • Substituted 6−membered n−heterocyclic compounds and their uses as neurological regulator
    Publication number: 20050130958
    Abstract: This invention relates to substituted 6-membered N-Herterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof, wherein R1, R2, X, Y, and Z are as defined in the description; their preparation methods, compositions comprising the same, and their use as inhibitors of FK560 binding proteases activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injuries or other related diseases.
    Type: Application
    Filed: December 5, 2002
    Publication date: June 16, 2005
    Inventors: Song Li, Aihua Nie, Beifen Shen, Lili Wang, Wuhong Pei, Junhai Xiao, Songcheng Yang, Liuhong Yun, Hongying Liu, Cuiling Shu, Hongxia Wang, Zihe Rao
  • Radioimaging probes and the use thereof
    Publication number: 20030194372
    Abstract: The present invention provides novel radioimaging probes for use in combination with clinical radioimaging techniques for the visualization of specific tissues or regions of the body. These probes can be packaged into a blood-borne delivery vehicle for targeted delivery to these specific tissues or regions. This invention further provides for the use of synthetic microemulsions or chemically modified human low-density lipoprotein (LDL), such as acetylated LDL (AcLDL), as delivery vehicles to target the radioimaging probes specifically to tissues or regions that contain high concentrations of LDL receptors.
    Type: Application
    Filed: May 6, 2003
    Publication date: October 16, 2003
    Inventors: Hu Liu, Lili Wang, Wu Xiao, Ping Liu